Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Low RiskFDA Drug
Medications & Supplements/Prescription Drugs

Sun Pharma Esomeprazole Magnesium Capsules Recalled for High Drug Potency

Agency Publication Date: September 26, 2022
Share:
Sign in to monitor this recall

Summary

Sun Pharmaceutical Industries Inc. is recalling approximately 14,352 bottles of Esomeprazole Magnesium Delayed-Release Capsules (generic Nexium) because testing showed the medication was superpotent. The recall affects 90-count bottles of both 20mg and 40mg strengths. While no incidents or injuries have been reported, the medication contains more of the active ingredient than specified on the label.

Risk

Superpotent drugs deliver a higher dose of medication than intended by a physician. This increases the risk of side effects or unexpected drug interactions for patients taking the medication.

What You Should Do

  1. This recall affects Sun Pharmaceutical Industries Esomeprazole Magnesium Delayed-Release Capsules (20mg and 40mg) sold in 90-count bottles (NDC 63304-734-90 and 63304-735-90).
  2. Check your medication bottle for lot numbers AC14299 (20mg) or AC14304 (40mg), both of which have an expiration date of December 2022.
  3. If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Sun Pharmaceutical Industries Inc. for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) if you have additional questions regarding this recall.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Esomeprazole Magnesium Delayed-Release Capsules, USP (20mg)
Variants: 20mg, 90 Capsules per bottle
Lot Numbers:
AC14299 (Exp 12/2022)
NDC:
63304-734-90

Manufactured by Ohm Laboratories Inc.; Distributed by Sun Pharmaceutical Industries, Inc.

Product: Esomeprazole Magnesium Delayed-Release Capsules, USP (40mg)
Variants: 40mg, 90 Capsules per bottle
Lot Numbers:
AC14304 (Exp 12/2022)
NDC:
63304-735-90

Manufactured by Ohm Laboratories Inc.; Distributed by Sun Pharmaceutical Industries, Inc.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 90891
Status: Resolved
Manufacturer: SUN PHARMACEUTICAL INDUSTRIES INC
Sold By: Pharmacies
Manufactured In: United States
Units Affected: 2 products (5712 bottles; 8640 bottles)
Distributed To: Nationwide
Agency Last Updated: October 6, 2022

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.